Response to Dawson et al: Letter to the Editor on ''A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK''

EXPERT REVIEW OF VACCINES

TAYLOR & FRANCIS LTD

1. Pfizer